| Dr Jessica Robin Scott, MD | |
|
10301 Glacier Hwy, Juneau, AK 99801-8561 | |
| (907) 789-2910 | |
| Not Available |
| Full Name | Dr Jessica Robin Scott |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 10301 Glacier Hwy, Juneau, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447342498 | NPI | - | NPPES |
| MD3430 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 6512 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bartlett Regional Hospital | Juneau, AK | Hospital |
| Mt Edgecumbe Hospital | Sitka, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bartlett Regional Hospital | 1759469174 | 25 |
News Archive
Frequent and/or long-term marijuana use may significantly increase a man's risk of developing the most aggressive type of testicular cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
Subthalamic nucleus deep brain stimulation can significantly improve the motor features of the Parkinson's disease in carefully selected patients. However, effects of subthalamic nucleus deep brain stimulation on the social adjustment, coping strategies and mental health-related quality of life of these patients remain unclear.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
› Verified 7 days ago
| Entity Name | Bartlett Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508044835 PECOS PAC ID: 1759469174 Enrollment ID: O20080424000506 |
News Archive
Frequent and/or long-term marijuana use may significantly increase a man's risk of developing the most aggressive type of testicular cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
Subthalamic nucleus deep brain stimulation can significantly improve the motor features of the Parkinson's disease in carefully selected patients. However, effects of subthalamic nucleus deep brain stimulation on the social adjustment, coping strategies and mental health-related quality of life of these patients remain unclear.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Robin Scott, MD 10301 Glacier Hwy, Juneau, AK 99801-8561 Ph: (907) 789-2910 | Dr Jessica Robin Scott, MD 10301 Glacier Hwy, Juneau, AK 99801-8561 Ph: (907) 789-2910 |
News Archive
Frequent and/or long-term marijuana use may significantly increase a man's risk of developing the most aggressive type of testicular cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
Subthalamic nucleus deep brain stimulation can significantly improve the motor features of the Parkinson's disease in carefully selected patients. However, effects of subthalamic nucleus deep brain stimulation on the social adjustment, coping strategies and mental health-related quality of life of these patients remain unclear.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
› Verified 7 days ago
Don Carl Schneider, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3220 Hospital Dr, Suite 100, Juneau, AK 99801 Phone: 907-586-2434 | |
Richard Willis Welling, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3220 Hospital Dr, Suite 100, Juneau, AK 99801 Phone: 907-790-7215 | |
Keegan Marie Jackson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3245 Hospital Dr, Juneau, AK 99801 Phone: 907-463-4040 | |
Dr. Kim C Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10301 Glacier Hwy, Juneau, AK 99801 Phone: 907-789-2910 Fax: 907-789-5545 | |
Dr. Sharon Elizabeth Fisher, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3220 Hospital Dr., 100, Juneau, AK 99801 Phone: 907-586-2434 Fax: 907-586-2446 | |
James Mckinney, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3268 Hospital Dr Ste A, Juneau, AK 99801 Phone: 907-796-8700 Fax: 907-796-8710 | |
Daniel Shinil Kim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Salmon Creek Ln, Juneau, AK 99801 Phone: 907-586-2434 |